OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 109 filers reported holding OCULAR THERAPEUTIX INC in Q3 2020. The put-call ratio across all filers is 1.19 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,632 | -77.6% | 1,475 | -63.2% | 0.00% | – |
| Q2 2023 | $20,661 | -20.8% | 4,012 | -19.1% | 0.00% | – |
| Q1 2023 | $26,084 | +86.3% | 4,957 | +4.9% | 0.00% | – |
| Q4 2022 | $14,000 | -30.0% | 4,725 | -2.1% | 0.00% | – |
| Q3 2022 | $20,000 | +33.3% | 4,825 | +29.5% | 0.00% | – |
| Q2 2022 | $15,000 | -16.7% | 3,725 | 0.0% | 0.00% | – |
| Q1 2022 | $18,000 | -82.9% | 3,725 | -75.3% | 0.00% | – |
| Q4 2021 | $105,000 | +128.3% | 15,076 | +229.5% | 0.00% | – |
| Q3 2021 | $46,000 | -4.2% | 4,576 | +35.5% | 0.00% | – |
| Q2 2021 | $48,000 | +17.1% | 3,376 | +35.0% | 0.00% | – |
| Q1 2021 | $41,000 | +241.7% | 2,501 | +316.1% | 0.00% | – |
| Q4 2020 | $12,000 | +33.3% | 601 | -47.7% | 0.00% | – |
| Q3 2020 | $9,000 | +28.6% | 1,150 | +27.8% | 0.00% | – |
| Q2 2020 | $7,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |